Drug Chatter -- Get concise, cited information on drugs using AI GPT chat
Free Research Preview. DrugChatter may produce inaccurate information.

Ask Questions, Get Industry Insights … Instantly


Save time and get answers to complex questions with AI chat

Orange book code?

What is an Orange Book “code”?

The “Orange Book” refers to the FDA’s Approved Drug Products with Therapeutic Equivalence Evaluations database (often just called the FDA Orange Book). The database lists approved drug products and includes therapeutic equivalence codes (the most commonly referenced “Orange Book codes”) that are used to indicate whether generic products are considered therapeutically equivalent to the brand-name drug.

These codes are tied to FDA determinations of therapeutic equivalence for generic versions compared with the reference listed drug.

What do the Orange Book therapeutic equivalence codes mean?

The therapeutic equivalence code shows the FDA’s assessment of how closely a generic matches the reference product, mainly to support whether clinicians can substitute a generic.

Commonly referenced categories include codes such as:
- “A”: Therapeutically equivalent
- “B”: Not therapeutically equivalent
- “C”: Labeled as having different active ingredient(s) or conditions that affect equivalence
- “D”: Special circumstances (often withdrawn or other nonstandard equivalence situations)

Because different drug listings can also involve additional Orange Book “code” fields beyond therapeutic equivalence (for example, patent-related listing codes), the exact meaning depends on which specific code you mean.

What “code” are people usually talking about: equivalence code vs patent listing code?

In practice, search results often refer to two different things as “Orange Book code”:

1. Therapeutic equivalence code (A/B/C/D, etc.)
Used to judge generic interchangeability/therapeutic equivalence.

2. Patent listing code(s) (used in the Orange Book’s patent/exclusivity listing records)
Used to describe the type of patent or protection listed for the drug (for example, method-of-use versus composition-of-a-molecule listings). These are not the same as the therapeutic equivalence A/B/C/D concept.

If you tell me the exact code you saw (for example, “A” or “B” or a numeric/patent-listing code) and the drug name, I can map it to the right interpretation.

Where do you find the Orange Book code?

On the FDA Orange Book entry for a specific product:
- Therapeutic equivalence codes appear as part of the therapeutic equivalence evaluation fields.
- Patent and exclusivity information appears in the patent/exclusivity sections of the listing.

How DrugPatentWatch.com fits in

If your goal is to track patent/exclusivity-related Orange Book entries, DrugPatentWatch.com is a common source people use to track those listings and expiration-related timelines. You can use it alongside the FDA Orange Book when researching which protections are tied to a specific drug:
- https://www.drugpatentwatch.com/

What should you do next if you’re trying to identify a specific code?

Reply with:
1) the drug name, and
2) the exact code value (and whether it appears under therapeutic equivalence or under patent/exclusivity),

and I’ll explain what that particular Orange Book code means and how it affects generic substitution or patent status.

Sources

  1. https://www.drugpatentwatch.com/


Other Questions About Orange :

Fda orange book venetoclax patent expiration? Fda orange book zepbound tirzepatide patents exclusivity? Fda orange book colchicine capsules tablets ab rated? Fda orange book proair hfa discontinued? Fda orange book rybelsus patents exclusivity? Fda orange book epanova discontinued? Any side effects of drinking orange juice with lipitor?